Moderna, Inc. logo

Moderna, Inc.

NASDAQ:MRNA

Overview | Financials
Company Name Moderna, Inc.
Symbol MRNA
Currency USD
Price 24.02
Market Cap 9,289,542,840
Dividend Yield 0%
52-week-range 23.15 - 170.47
Industry Biotechnology
Sector Healthcare
CEO Mr. Stephane Bancel
Website https://www.modernatx.com

An error occurred while fetching data.

About Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent

Related Stocks

Illumina, Inc. logo

Illumina, Inc.

ILMN

78.21 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.13 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

421.16 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

509.42 USD

Biogen Inc. logo

Biogen Inc.

BIIB

120.37 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

86.52 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

32.29 USD

Financials

Numbers are in millions USD

Numbers are in millions USD